Vision Mission & Strength
R & D
Niprolac Oral Sol
Starcal D Forte
NIPRO JMI Pharma Ltd. (NJP) is contributing in developing a world-class practicein the pharma industry of Bangladesh by bridling the unment challenges in healthcare sector. It is one of the fastest growing pharmaceutical companies in Bangladesh, started its journey in 2012 with collaboration of NIPRO Corporation; a Japan based giant multinational company, a press release said.
NIPRO JMI Pharma Limited (NJP) has introduced Linagliptin (Lijenta) and Empagliflozin (Empa), which are the breakthroughs in diabetic management and aiding millions of diabetic patients in the country....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1426 at Corporate office....
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka.....
Ciali (Tadalafil) is a selective phosphodiesterase type 5 (PDE5) inhibitor. Inhibition of
PDE5 increases cGMP in smooth muscle cells. Cyclic GMP causes smooth muscle
relaxation and increased blood flow into the corpus cavernosum, causing penile
erection. PDE5 also is present in smooth muscles of the prostate and bladder wall.
Inhibiting PDE5 increases cGMP concentrations leading to relaxation of smooth muscle
in the prostate and bladder. Smooth muscle relaxation may improve blood flow to the
urinary tract and widen the opening of the bladder neck, resulting in improved voiding.